Codexis to Participate in TD Cowen 46th Annual Health Care Conference
Codexis (NASDAQ: CDXS) will attend the TD Cowen 46th Annual Health Care Conference in Boston March 2-4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Codexis (NASDAQ: CDXS) will attend the TD Cowen 46th Annual Health Care Conference in Boston March 2-4, 2026. Management will join a fireside chat on March 3, 2026 at 11:50 am ET. A live webcast will be available on the company's Investor Relations site and replayed for 90 days.
Details
News Market Reaction – CDXS
On Feb 17, the day this news came out, CDXS closed 0.83% above the previous close.
Data tracked by StockTitan Argus for the Feb 17 session.
Key Figures
- Conference dates
- March 2–4, 2026
- TD Cowen 46th Annual Health Care Conference
- Fireside chat time
- 11:50 am ET
- Management presentation on March 3, 2026
- Replay period
- 90 days
- Archived webcast availability after event
- Current price
- $1.20
- Prior to conference participation news
- 52-week high
- $4.46
- Pre-news 52-week range upper bound
- 52-week low
- $1.12
- Pre-news 52-week range lower bound
- Market cap
- $108,389,260
- Equity value prior to conference update
- Short interest
- 14.97%
- Reported short interest as of latest data
Historical Context
-
ISO 9001:2015 certification for HQ, R&D labs, and non-GMP manufacturing.
-
Axolabs evaluation agreement for ECO Synthesis oligonucleotide platform.
-
Lease of 34,000 sq ft GMP site to expand internal production.
-
Q3 2025 results with revenue decline, layoffs, and cost actions.
-
Nitto Denko Avecia evaluation of ECO Synthesis for siRNA manufacturing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 46th Annual Health Care Conference, being held March 2-4, 2026, in Boston, Massachusetts.
Management will participate in a fireside chat on Tuesday, March 3, 2026, at 11:50 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis® manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Georgia Erbez
(650) 421-8100
ir@codexis.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.